Organizational and direct support maintenance repair parts and special tools list (including depot maintenance repair parts and special tools) for viewers, driver's night vision, AN/VVS-2(V)1 (NSN 5855-00-629-5278), AN/VVS-2(V)2 (NSN 5855-01-057-1880), AN/VVS-2(V)3 (NSN 5855-01-105-7793), AN/VVS-2(V)1A (NSN 5855-01-096-0871), and AN/VVS-2(V)2A (NSN 5855-01-096-0872).

Includes index.

Organizational and direct support maintenance manual : night vision sights, individual served weapon AN/PVS-2 (NSN 5855-00-087-2947), AN/PVS-2A (NSN 5855-00-179-3708), and AN/PVS-2B (NSN 5855-00-760-3869).

"November 1977."

Operator's manual : viewers, driver's, night vision, AN/VVS-2(V)1 (NSN 5855-00-629-5278), AN/VVS-2(V)1A (NSN 5855-01-096-0871), AN/VVS-2(V)2 (NSN 5855-01-057-1880), AN/VVS-2(V)2A (NSN 5855-01-096-0872), AN/VVS-2(V)3 (NSN 5855-01-105-7793).

"August 1982."

Organizational and direct support maintenance, repair parts, and special tools lists (including depot maintenance repair parts and special tools) for night vision sight, crew served weapons AN/TVS-2 (NSN 5855-00-087-3144), AN/TVS-2A (NSN 5855-00-791-3358), and AN/TVS-2B (NSN 5855-00-484-8638).

Includes index.

Organizational, direct support, and general support maintenance repair parts and special tools lists (including depot maintenance repair parts and special tools) for radio terminal sets AN/TRC-145(V)1, AN/TRC-145(V)2, AN/TRC-145(V)3, AN/TRC-145A(V)1, AN/TRC-145A(V)2, and AN/TRC-145A(V)3, (NSN 5820-00-791-3365).

Includes index.

DS, GS, and depot maintenance manual : searchlights, visible light-infrared, AN/GSS-14, AN/GSS-14A, AN/GSS-14B, AN/GSS-18, AN/GSS-18A ... and searchlight set, infrared, AN/VSS-2.

Includes index.

Plastic laminated diagrams for direct support, general support, and depot maintenance manual : searchlights, visible light-infrared, AN/GSS-14 (NSN 6230-00-933-4468) ... and searchlight set, infrared, AN/VSS-2 (NSN 5855-00-878-4299).

"5 May 1982."

Operator and organizational maintenance manual including repair parts and special tool lists : test sets, telegraph, AN/GGM-15(V)1 (NSN 6625-00-464-1702), AN/GGM-15(V)2 (NSN 6625-00-442-6131).

Includes index.

Operators and organizational maintenance manual : test facility kit AN/GRM-95(V)2, (NSN 6625-01-104-8926).

Includes index.

Organizational maintenance repair parts and special tools lists for test sets AN/GGM-15(V)1 (NSN 6625-00-464-1702), AN/GGM-15(V)2 (NSN 6625-00-442-6131), and generator, signal ... analyzer, signal distortion ... oscilloscope ... dolly, test equipment V-434/GGM-15(V) (NSN 6625-00-435-7775).

Includes index.

Hand receipt covering contents of Components of End Item (COEI), Basic Issue Items (BII), and Additional Authorization List (AAL) for receiving set, radio, AN/TRQ-32(V), including AN/TRQ-32(V)1 NSN 5895-01-167-7655, AN/TRQ-32(V)2 NSN 5895-01-167-7655.

"November 1989."

Still picture camera set KS-15(1) and camera equipment AN/GFQ-2 : operation and maintenance.

"October 1958."

Hand receipt covering contents of components of end items (COEI), basic issue items (BII), and additional authorization list (AAL) for truck, cargo, 1 1/4 ton, 4 x 4, M880 (2320-00-579-8942)...; truck, cargo, 1 1/4 ton, 4 x 2, M890 (2320-00-579-8991)...; truck, ambulance, 1 1/4 ton, 4 x 2, M886 (2310-00-579-9078); truck, ambulance, 1 1/4 ton, 4 x 4, M893 (2310-00-125-5679); truck, telephone maintenance, tactical, 1 1/4 ton, 4 x 4, M888 (2320-01-044-0333).

"May 1983."

Treatment of partial-thickness burns: A prospective, randomized trial using Transcyte (TM)

Background: The purpose of the present study was to compare the effectiveness of three burns dressings (TransCyte, a bio-engineered skin substitute; Biobrane; and Silvazine cream (silver sulphadiazine and 0.2% chlorhexidine)), in treating children with partial-thickness burns. The primary objective was to determine the days until greater than or equal to90% re-epithelialization. The secondary objectives were to evaluate the number of wounds requiring autografting and the number of dressing changes/local wound care required. Methods: Study wounds were identified on each patient and the patients were randomized to receive TransCyte or Biobrane or Silvazine. Assessment of study wound closure began at 2 days after treatment and continued at least every other day thereafter until the wounds re-epithelialized or were autografted. A laser Doppler imaging system was used as an adjunct to assessing the depth of the burn. Results: Thirty-three patients with 58 wound sites enrolled in the study (TransCyte, n = 20, Biobrane, n = 17; Silvazine, n = 21). Mean time to re-epithelialization was 7.5 days for TransCyte, 9.5 days for Biobrane, and 11.2 days for Silvazine. The number of wounds requiring autografting were 5/21 (24%) for Silvazine, 3/17 (17%) for Biobrane, and 1/20 (5%) for TransCyte. Conclusions: When used in partial-thickness burns in children, TransCyte promotes fastest re-epithelialization and required less overall dressings then Biobrane or Silvazine. Patients who received Silvazine or Biobrane require more autografting than those treated with TransCyte.

Protease-activated receptor-2 peptides activate neurokinin-1 receptors in the mouse isolated trachea

Protective roles for protease-activated receptor-2 (PAR2) in the airways including activation of epithelial chloride (Cl-) secretion are based on the use of presumably PAR(2)-selective peptide agonists. To determine whether PAR(2) peptide-activated Cl- secretion from mouse tracheal epithelium is dependent on PAR(2), changes in ion conductance across the epithelium [short-circuit current (I-SC)] to PAR(2) peptides were measured in Ussing chambers under voltage clamp. In addition, epithelium and endothelium-dependent relaxations to these peptides were measured in two established PAR(2) bioassays, isolated ring segments of mouse trachea and rat thoracic aorta, respectively. Apical application of the PAR(2) peptide SLIGRL caused increases in I-SC, which were inhibited by three structurally different neurokinin receptor-1 (NK1R) antagonists and inhibitors of Cl- channels but not by capsaicin, the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP(8-37), or the nonselective cyclooxygenase inhibitor indomethacin. Only high concentrations of trypsin caused an increase in I-SC but did not affect the responses to SLIGRL. Relaxations to SLIGRL in the trachea and aorta were unaffected by the NK1R antagonist nolpitantium (SR 140333) but were abolished by trypsin desensitization. The rank order of potency for a range of peptides in the trachea I-SC assay was 2-furoyl-LIGRL > SLCGRL > SLIGRL > SLIGRT > LSIGRL compared with 2-furoyl-LIGRL > SLIGRL > SLIGRT > SLCGRL (LSIGRL inactive) in the aorta relaxation assay. In the mouse trachea, PAR(2) peptides activate both epithelial NK1R coupled to Cl- secretion and PAR(2) coupled to prostaglandin E-2-mediated smooth muscle relaxation. Such a potential lack of specificity of these commonly used peptides needs to be considered when roles for PAR(2) in airway function in health and disease are determined.